Smaglo, M.D., FACP Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine Present Title & Affiliation Primary Appointment Professor, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Education & Training Degree-Granting Education Postgraduate Training Licenses & Certifications Experience & Service Faculty Academic Appointments Associate Professor, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2026 Assistant Professor, Internal Medicine, Hematology/Oncology, Baylor College of Medicine, Houston, Texas, 2016 - 2020 Assistant Professor, Internal Medicine, Hematology/Oncology, MedStar Georgetown University Hospital, Washington, District of Columbia, 2013 - 2016 Administrative Appointments/Responsibilities Advisor to Goal Concordant Care Program, Goal Concordant Care Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present GIMO Faculty Recruitment Committee, Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present Fellowship Rotation Director, GastroIntestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present Committee member representing MD Anderson, Break Through Cancer Clinical Consortium, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present working group leader - pancreatic cancer clinical trials, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2021 - Present Medical Director, Internal Medicine, Baylor College of Medicine, Houston, Texas, 2018 - 2020 Extramural Institutional Committee Activities Member, Medical Records Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present Member, Data and Safety Monitoring Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present Editorial Activities Editorial Board, BMC Cancer, 2023 - 2025 Associate Editor, Pancreatic Cancer, Pancreatology, 2023 - Present Honors & Awards Professional Memberships Texas Society of Clinical Oncology 2018 - 2021 American Association for the Advancement of Science 2014 - Present American Association for Cancer Research 2012 - Present American Society of Clinical Oncology 2010 - Present American College of Physicians 2006 - Present Sigma Xi 2002 - Present Selected Presentations & Talks Local Presentations 2026

Neither is stronger
PlexusDx makes maintenance straightforward by shipping your weekly injections on a predictable schedule and maintaining flat monthly pricing throughout your treatment journeyno surprise increases as your dose stabilizes
The mechanism of action of Rybelsus is grounded in its ability to enhance the secretion of insulin from the pancreas in a glucose-dependent manner